Literature DB >> 16109978

Clinical and pathologic features of familial interstitial pneumonia.

Mark P Steele1, Marcy C Speer, James E Loyd, Kevin K Brown, Aretha Herron, Susan H Slifer, Lauranell H Burch, Momen M Wahidi, John A Phillips, Thomas A Sporn, H Page McAdams, Marvin I Schwarz, David A Schwartz.   

Abstract

RATIONALE: Several lines of evidence suggest that genetic factors and environmental exposures play a role in the development of pulmonary fibrosis.
OBJECTIVES: We evaluated families with 2 or more cases of idiopathic interstitial pneumonia among first-degree family members (familial interstitial pneumonia, or FIP), and identified 111 families with FIP having 309 affected and 360 unaffected individuals.
METHODS: The presence of probable or definite FIP was based on medical record review in 28 cases (9.1%); clinical history, diffusing capacity of carbon monoxide (DL(CO)), and chest X-ray in 16 cases (5.2%); clinical history, DL(CO), and high-resolution computed tomography chest scan in 191 cases (61.8%); clinical history and surgical lung biopsy in 56 cases (18.1%); and clinical history and autopsy in 18 cases (5.8%).
RESULTS: Older age (68.3 vs. 53.1; p < 0.0001), male sex (55.7 vs. 37.2%; p < 0.0001), and having ever smoked cigarettes (67.3 vs. 34.1%; p < 0.0001) were associated with the development of FIP. After controlling for age and sex, having ever smoked cigarettes remained strongly associated with the development of FIP (odds ratio(adj), 3.6; 95% confidence interval, 1.3-9.8). Evidence of aggregation of disease was highly significant (p < 0.001) among sibling pairs, and 20 pedigrees demonstrated vertical transmission, consistent with autosomal dominant inheritance. Forty-five percent of pedigrees demonstrated phenotypic heterogeneity, with some pedigrees demonstrating several subtypes of idiopathic interstitial pneumonia occurring within the same families.
CONCLUSIONS: These findings suggest that FIP may be caused by an interaction between a specific environmental exposure and a gene (or genes) that predisposes to the development of several subtypes of idiopathic interstitial pneumonia.

Entities:  

Mesh:

Year:  2005        PMID: 16109978      PMCID: PMC2718398          DOI: 10.1164/rccm.200408-1104OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  38 in total

1.  FAMILIAL INTERSTITIAL PULMONARY FIBROSIS.

Authors:  E W HUGHES
Journal:  Thorax       Date:  1964-11       Impact factor: 9.139

2.  Adult lipidosis resembling Niemann-Pick's disease.

Authors:  R D TERRY; W M SPERRY; B BRODOFF
Journal:  Am J Pathol       Date:  1954 Mar-Apr       Impact factor: 4.307

3.  Familial chronic interstitial pneumonia.

Authors:  N H Solliday; J A Williams; E A Gaensler; R E Coutu; C B Carrington
Journal:  Am Rev Respir Dis       Date:  1973-08

4.  Familial Hamman-Rich syndrome. Report of eight cases.

Authors:  P Swaye; H S Van Ordstrand; L J McCormack; S E Wolpaw
Journal:  Dis Chest       Date:  1969-01

5.  Familial idiopathic pulmonary fibrosis: clinical features and outcome.

Authors:  Hong-Lyeol Lee; Jay H Ryu; Michael H Wittmer; Thomas E Hartman; James F Lymp; Henry D Tazelaar; Andrew H Limper
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

6.  Family-based case-control study of cigarette smoking and Parkinson disease.

Authors:  W K Scott; F Zhang; J M Stajich; B L Scott; M A Stacy; J M Vance
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

7.  Determinants of progression in idiopathic pulmonary fibrosis.

Authors:  D A Schwartz; D S Van Fossen; C S Davis; R A Helmers; C S Dayton; L F Burmeister; G W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  1994-02       Impact factor: 21.405

Review 8.  The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations.

Authors:  R A DePinho; K L Kaplan
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

9.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm).

Authors:  A W Musk; P J Zilko; P Manners; P H Kay; M I Kamboh
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

10.  Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members.

Authors:  P B Bitterman; S I Rennard; B A Keogh; M D Wewers; S Adelberg; R G Crystal
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

View more
  141 in total

Review 1.  Telomerase and idiopathic pulmonary fibrosis.

Authors:  Mary Armanios
Journal:  Mutat Res       Date:  2011-11-04       Impact factor: 2.433

Review 2.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 3.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 4.  Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Harikrishna Tanjore; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

5.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

6.  ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.

Authors:  Ulla Hodgson; Ville Pulkkinen; Morag Dixon; Myriam Peyrard-Janvid; Marko Rehn; Paivi Lahermo; Vesa Ollikainen; Kaisa Salmenkivi; Vuokko Kinnula; Juha Kere; Pentti Tukiainen; Tarja Laitinen
Journal:  Am J Hum Genet       Date:  2006-05-09       Impact factor: 11.025

Review 7.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 8.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

Review 9.  High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis.

Authors:  N Sverzellati; M De Filippo; T Bartalena; S Piciucchi; M Zompatori
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

10.  MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis.

Authors:  Marco Checa; Víctor Ruiz; Martha Montaño; Rafael Velázquez-Cruz; Moisés Selman; Annie Pardo
Journal:  Hum Genet       Date:  2008-10-14       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.